BVS Bioventus Inc.

NASDAQ
$13.81

Bioventus Inc. (BVS) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is $0.17 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.8% since its last earnings release on August 5, 2026.

Bioventus Inc. Missed Expectations, Reaffirms
Wednesday, August 5, 2026 · 7:30 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 7:30 AM ET
Earnings Whisper
-
vs $0.17
Rev est $149.53M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $13.99

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Bioventus Inc.

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.